Doxfyn A 400mg/30mg Tablet is used to treat asthma and chronic obstructive pulmonary disorder (a lung disorder in which the flow of air to the lungs is blocked). It helps in relaxing the muscles of the air passages and making it easier to breathe.

Doxfyn A 400mg/30mg Tablet is a combination of two medicines: Doxfyn A 400mg/30mg Tablet1 and Doxfyn A 400mg/30mg Tablet2.

Uses of Doxfyn A Tablet

Chronic obstructive pulmonary disease (COPD)

Benefits of Doxfyn A Tablet

In Chronic obstructive pulmonary disease (COPD)

Doxfyn A 400mg/30mg Tablet helps the airways in your lungs stay open. It relaxes the muscles of these airways. This makes it easier for air to get in and out. It will relieve symptoms such as tightness in your chest, shortness of breath, wheezing and coughing and help you carry out your daily activities more easily. This medicine is safe and effective. It usually starts to work within a few minutes and the effects can last up to several hours. Do not stop using it unless you are advised to by your doctor.

Side effects of Doxfyn A Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Doxfyn A

Nausea
Vomiting
Stomach pain/epigastric pain
Headache
Irritation
Insomnia (difficulty in sleeping)
Fast heart rate
Extrasystoles
Increased respiratory rate

How to use Doxfyn A Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Doxfyn A 400mg/30mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Avoid Doxfyn A 400mg/30mg Tablet with caffeine and chocolate as well as food containing caffeine and chocolate such as tea leaves, cocoa beans.

Safety advice

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Doxfyn A 400mg/30mg Tablet. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

Doxfyn A 400mg/30mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

Information regarding the use of Doxfyn A 400mg/30mg Tablet during breastfeeding is not available. Please consult your doctor.

Driving

CONSULT YOUR DOCTOR

It is not known whether Doxfyn A 400mg/30mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Kidney

CAUTION

Doxfyn A 400mg/30mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Doxfyn A 400mg/30mg Tablet may be needed. Please consult your doctor.

Liver

CAUTION

Doxfyn A 400mg/30mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Doxfyn A 400mg/30mg Tablet may be needed. Please consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Doxfyn A 400mg/30mg Tablet

₹10.0/Tablet

Ventidox-Bro Tablet

Mankind Pharma Ltd

₹7.26/tablet

27% cheaper

Doxomax XP Tablet

Aristo Pharmaceuticals Pvt Ltd

₹6.13/tablet

39% cheaper

Spirodin-AX Tablet

Koye Pharmaceuticals Pvt ltd

₹7.9/tablet

21% cheaper

Broncocet DX Tablet

Seagull Laboratories (I) Pvt Ltd

₹6.9/tablet

31% cheaper

Yoflin-AX 400mg/30mg Tablet

Pax Healthcare

₹10/tablet

same price

View all substitutes

Quick tips

Doxfyn A Tablet

You have been prescribed Doxfyn A 400mg/30mg Tablet for prevention and treatment of asthma and chronic obstructive pulmonary disease (COPD).
It does not work right away and should not be used to relieve sudden breathing problems. Always keep a fast-acting (rescue) inhaler with you.
If at any time your breathing gets worse, please contact your doctor or nurse for advice straightaway.
Do not smoke. Smoking causes irritation and damage to the lungs and will make your condition worse.
Do not discontinue use without consulting your doctor, even if you feel better.

Fact Box

Habit Forming

Therapeutic Class

RESPIRATORY

Patient concerns

i m suffering from breathing problem cough chest infame . Do tell chronic obstructive pulmonary disease .So tell which medicines should i take to treat this problem.

Dr. Anshum Aneja Arora

Pulmonology

It is less likely you have copd at this age You need detailed check up and spirometry test for same

What is chronic pulmonary thromboembolism?

Dr. Saurabh Arora

Cardiology

U can Google for details

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

PubChem. Doxofylline. [Accessed 01 Apr. 2019] (online) Available from:
Ambroxol. 2001. [Accessed 01 Apr. 2019] (online) Available from:
ScienceDirect. Doxofylline. [Accessed 01 Apr. 2019] (online) Available from:
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from:

Marketer details

Name: Uniphar Biotech Private Limited

Address: SCF- 296-97, Ist & IInd Floor, M.Market, Manimajra , Chandigarh ,India

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.